PROBLEMS AND PERSPECTIVES OF ANTIBACTERIAL THERAPY OF CHRONIC PSEUDOMONAS INFECTION IN PATIENTS WITH CYSTIC FIBROSIS

Abstract

Authors analyze the data on effectiveness and safety of new regimen of combined antibacterial therapy with solution of tobramycin for inhalations 300 mg/5 ml (Tobi). This drug was administered to 23 patients with cystic fibrosis during 15 days at the time of an exacerbation. It was shown that addition of inhaled solution of tobramycin to the antibiotics increased clinical and bacteriological effectiveness of treatment of bronchopulmonary process.Key words: children, chronic Pseudomonal infection, tobramycin for inhalations.(Voprosy sovremennoi pediatrii — Current Pediatrics. 2010;9(2):94-98)